Kezdőlap・Részvénylista・Novo Nordisk A-S (Class B)
Search

Novo Nordisk A-S (Class B)

Lezárt

269.2 -0.09

Vétel

Ár frissítés 2026. nov. 6. 15:54 UTC

VételEladás

Áttekintés

Árfolyamváltozás megosztása

24 óra

Jelenlegi

Minimum

266.64

Maximum

269.8

Fő mutatók

By Trading Economics

Bevétel

-28B

21B

Értékesítés

-18B

78B

P/E

Szektor átlag

10.397

51.78

Egy részvényre jutó nyereség

6.18

Osztalékhozam

4.33

Profit margin

26.742

Munkavállalók

66,700

EBITDA

-31B

39B

Ajánlások

By TipRanks

Ajánlások

Vétel

12 hónapos előrejelzés

+9.53% upside

Osztalékok

By Acuity

Osztalékhozam

Szektor átlag

4.33%

1.96%

Következő eredményjelentés

2027. febr. 3.

Piaci statisztika

By TradingEconomics

Piaci kapitalizáció

-181B

1.2T

Előző nyitás

269.29

Előző zárás

269.2

Novo Nordisk A-S (Class B) Chart

A múltbeli teljesítmény nem megbízható mutatója a jövőbeli eredményeknek.

Kapcsolódó hírek

2026. nov. 7. 22:42 UTC

UK Retail Sales Monitor Set for Release Amid Cautious Sentiment and Mixed Economic Signals

Olvasás

2026. nov. 7. 22:42 UTC

Mexico's Inflation Rate YoY Expected to Rise Ahead of November 9 Release, Heightening Concerns Over Persistent Price Pressures and Potential Monetary Policy Adjustments.

Olvasás

2026. nov. 7. 22:11 UTC

Mexico's Upcoming Inflation Rate Release on November 9, 2026, Sparks Caution Amid Global Economic Concerns.

Olvasás

2026. nov. 7. 22:11 UTC

Japan's Current Account Surplus Forecasted at JPY 3.35 Trillion Amidst Cautious Market Sentiment Following Nikkei Index Plunge

Olvasás

2026. nov. 7. 22:01 UTC

Spanish Consumer Confidence Index Release on November 10, 2026, Amid Rising Concerns Over Geopolitical Tensions and Inflationary Pressures.

Olvasás

2026. nov. 7. 21:52 UTC

Japan's Household Spending Expected to Decline 3.1% YoY Amid Economic Challenges and Market Skepticism

Olvasás

2026. nov. 7. 21:52 UTC

Australia's Westpac Consumer Confidence Index set for release on November 9, amid global inflation concerns and tech market volatility.

Olvasás

2026. nov. 7. 21:52 UTC

Australia's Westpac Consumer Confidence Index set for release amid global market volatility and cautious sentiment ahead of key economic data.

Olvasás

2026. nov. 7. 21:52 UTC

Japan's Household Spending MoM data for September set to release on November 9, with a modest forecast increase of 0.3% amid cautious market sentiment and recent declines in the Nikkei index.

Olvasás

2026. nov. 7. 21:52 UTC

UK GDP 3-Month Average Data Release on November 12 Sparks Cautious Optimism Amid Economic Uncertainties.

Olvasás

2026. nov. 7. 21:43 UTC

India's Inflation Rate Expected to Rise to 5.93% in October Amidst Geopolitical Tensions and Positive Equity Market Sentiment

Olvasás

2026. nov. 7. 21:43 UTC

South Korea's October 2026 unemployment rate release on November 10 expected to reflect ongoing positive employment trends amid global market volatility.

Olvasás

2026. nov. 7. 21:33 UTC

Euro Area Expected to Report €4.5 Billion Trade Deficit Amid Weak Retail Sales and Rising Inflation Concerns

Olvasás

2026. nov. 7. 21:33 UTC

Euro Area Employment Change Report Forecasts 0.2% Increase Amid Global Labor Market Optimism and Inflation Concerns

Olvasás

2026. nov. 7. 21:23 UTC

Brazil's Central Bank to Provide Key Insights on Interest Rates Amid Global Economic Pressures in Upcoming November 9 Readout.

Olvasás

2026. nov. 7. 21:03 UTC

API Crude Oil Stock Change Report on November 10 Expected Amid Geopolitical Tensions and Volatile WTI Prices at $90 per Barrel.

Olvasás

2026. nov. 7. 20:41 UTC

The CHF/JPY currency pair remains stable near the upper end of its one-month trading range, following Friday's strong U.S. non-farm payroll report.

Olvasás

2026. nov. 7. 20:41 UTC

The EUR/SEK currency pair is roughly flat since Friday's close, amid speculation about potential interest rate hikes following recent U.S. labor market data.

Olvasás

2026. nov. 7. 20:41 UTC

GBP/CAD remained roughly flat over the weekend, positioned near the upper end of its one-month trading range amid speculation of potential Fed interest rate hikes.

Olvasás

2026. nov. 7. 20:41 UTC

The EUR/JPY currency pair has seen a slight increase since Friday's close, remaining stable during the weekend market closure.

Olvasás

2026. nov. 7. 20:41 UTC

The EUR/NZD currency pair is lower since Friday's close, amid speculation of potential U.S. interest rate hikes following strong labor market data.

Olvasás

2026. nov. 7. 20:41 UTC

Macro News

The IBEX 35 Index is declining during after-market hours amid regulatory concerns in the pharmaceutical sector and fears of tighter AI regulations.

Olvasás

2026. nov. 7. 20:33 UTC

China's Q3 2026 Current Account Release Expected to Show Continued Strong Surplus Amid Positive Trade Dynamics

Olvasás

2026. nov. 7. 20:33 UTC

Italy's Balance of Trade data set for November 13 reveals a forecasted surplus of €1.85 billion amid cautious market sentiment and concerns over rising energy costs impacting trade dynamics.

Olvasás

2026. nov. 7. 20:03 UTC

South Africa's Q3 2026 Unemployment Rate Release on November 10 Expected Amidst High Rates and Global Job Market Concerns.

Olvasás

2026. nov. 7. 19:53 UTC

Italy's Industrial Production Expected to Grow 0.7% MoM Amid Mixed European Economic Sentiment Ahead of November Release

Olvasás

2026. nov. 7. 19:33 UTC

UK Q3 2026 GDP Growth Rate Release on November 12 Expected at 0.7% Amid Investor Caution Over Geopolitical Uncertainties and Inflationary Pressures.

Olvasás

2026. nov. 7. 19:33 UTC

UK Goods Trade Balance Expected to Widen Deficit to -19.2 Billion GBP Amid Economic and Geopolitical Pressures

Olvasás

2026. nov. 7. 19:33 UTC

UK Monthly GDP MoM Release on November 12 Forecasts No Growth Amid Cautious Optimism and Inflation Concerns.

Olvasás

2026. nov. 7. 19:33 UTC

UK's Non-EU Goods Trade Balance Data Set for Release on November 12, Expected to Reflect International Trade Trends Amid Cautious Market Sentiment.

Olvasás

Novo Nordisk A-S (Class B) Előrejelzés

Célár

By TipRanks

9.53% elmozdulás felfelé

12 hónapos előrejelzés

Átlag 1,162.73 DKK  9.53%

Magas 1,550 DKK

Alacsony 720 DKK

11 Wall Street elemző 12 hónapos célárain alapulva a(z)Novo Nordisk A-S (Class B) termékhez az elmúlt 3 hónapban.

Értékelési konszenzus

By TipRanks

Vétel

11 ratings

7

Vétel

2

Tartás

2

Eladás

11 Wall Street elemző célárain alapulva a(z)Novo Nordisk A-S (Class B) termékhez az elmúlt 3 hónapban.

Pénzügyek

Értékesítési és adminisztrációs költségek

Üzemeltetési költségek

Adózás előtti nyereség

Értékesítés

Értékesítési költség

Értékesítési bruttó nyereség

Kamatköltség a hitelre

EBITDA

Üzemi nyereség

$

Rólunk Novo Nordisk A-S (Class B)

Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. The Diabetes and Obesity care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides insulin pens, growth hormone pens, and injection needles. In addition, it offers smart solutions for diabetes treatment, such as smart insulin pens and Dose Check, an insulin dose guidance application. The company has a collaboration agreement with UNICEF to tackle childhood obesity; and with Valo Health, Inc. to discover and develop novel drug programmes for cardiometabolic space. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
help-icon Live chat